Effect of hemostatic risk factors on the individual probability of thrombosis during pregnancy and the puerperium

被引:40
作者
Gerhardt, A [1 ]
Scharf, RE [1 ]
Zotz, RB [1 ]
机构
[1] Univ Dusseldorf, Inst Haemostaseol & Tranfusionsmed, D-40225 Dusseldorf, Germany
关键词
pregnancy; venous thrombosis; risk factors; pulmonary embolism;
D O I
10.1055/s-0037-1613602
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In a retrospective study of 190 women with a first history of venous thromboembolism during pregnancy and the. puerperium and 190 age-matched women with at least one prior pregnancy and no history of venous thromboembolism, the individual probability of thrombosis was determined. Assuming an overall risk of 1 in 1500 pregnancies, the probability of pregnancy-related thrombosis in carriers of homozygous factorV Leiden was 1 in 80 (odds ratio 20.6, p=0.005) and among carriers of combined heterozygous factor V Leiden and heterozygous G20210A mutation in the prothrombin gene 1 in 20 (odds ratio 88, p<0.001). The probability of thrombosis per pregnancy among women with elevated levels of factorVIII:C (>172 % activity) was 1 in 385 (odds ratio 4.5, p<0.001) and among those with increased levels of von Willebrand factor antigen (>190 %) 1 in 435 (odds ratio 4.0, p=0.002), independent of elevated factorVIII:C levels. The high prevalence of combined and homozygous defects of hemostatic components (21.6%) in patients as compared with normal women (0.86%) supports the concept that venous thromboembolism is a multicausal disorder.
引用
收藏
页码:77 / 85
页数:9
相关论文
共 43 条
[11]   A CANDIDATE GENETIC RISK FACTOR FOR VASCULAR-DISEASE - A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE [J].
FROSST, P ;
BLOM, HJ ;
MILOS, R ;
GOYETTE, P ;
SHEPPARD, CA ;
MATTHEWS, RG ;
BOERS, GJH ;
DENHEIJER, M ;
KLUIJTMANS, LAJ ;
VANDENHEUVEL, LP ;
ROZEN, R .
NATURE GENETICS, 1995, 10 (01) :111-113
[12]   Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. [J].
Gerhardt, A ;
Scharf, RE ;
Beckmann, MW ;
Struve, S ;
Bender, HG ;
Pillny, M ;
Sandmann, W ;
Zotz, RB .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (06) :374-380
[13]   Genetic susceptibility to pregnancy-related venous thromboembolism: Roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations [J].
Grandone, E ;
Margaglione, M ;
Colaizzo, D ;
D'Andrea, G ;
Cappucci, G ;
Brancaccio, V ;
Di Minno, G .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 179 (05) :1324-1328
[14]   Thrombosis in pregnancy: maternal and fetal issues [J].
Greer, IA .
LANCET, 1999, 353 (9160) :1258-1265
[15]   The challenge of thrombophilia in maternal-fetal medicine. [J].
Greer, IA .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (06) :424-425
[16]   Epidemiology, risk factors and prophylaxis of venous thrombo-embolism in obstetrics and gynaecology [J].
Greer, IA .
BAILLIERES CLINICAL OBSTETRICS AND GYNAECOLOGY, 1997, 11 (03) :403-430
[17]   Activated protein C resistance (factor V Leiden) associated with thrombosis in pregnancy [J].
Hallak, M ;
Senderowicz, J ;
Cassel, A ;
Shapira, C ;
Aghai, E ;
Auslender, R ;
Abramovici, H .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1997, 176 (04) :889-893
[18]   RESISTANCE TO ACTIVATED PROTEIN-C AS A BASIS FOR VENOUS THROMBOEMBOLISM ASSOCIATED WITH PREGNANCY AND ORAL-CONTRACEPTIVES [J].
HELLGREN, M ;
SVENSSON, PJ ;
DAHLBACK, B .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 173 (01) :210-213
[19]  
Kearon C, 1998, ANN INTERN MED, V128, P663, DOI 10.7326/0003-4819-128-8-199804150-00011